论文部分内容阅读
2009年9月15日,一项由41个国家500多个医疗中心参与的大型临床研究结果在北京公布。这项抗高血压药物对房颤患者心脑血管事件和死亡风险的评估研究(ACTIVE-I)显示,早期应用抗高血压药物厄贝沙
On September 15, 2009, a large-scale clinical study involving more than 500 medical centers in 41 countries was announced in Beijing. The anti-hypertensive drugs in patients with atrial fibrillation assessment of cardiovascular events and death risk assessment (ACTIVE-I) shows that the early use of anti-hypertensive drugs irbesa